This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.
Review paper

Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others

Volume: 15, Issue: 1, Pages: 13 - 30
Published: Sep 26, 2017
Abstract
TP53, encoding the tumour-suppressor p53, is the most frequently mutated gene across all human cancers. Similar to other transcription factors, p53 has proved notoriously difficult to target therapeutically; to date, no p53-targeted therapies have entered the clinic. The diversity ofTP53 mutations, which can be categorized across a spectrum of different functional classes, is increasingly recognized as an additional challenge to developing...
Paper Details
Title
Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others
Published Date
Sep 26, 2017
Volume
15
Issue
1
Pages
13 - 30
© 2025 Pluto Labs All rights reserved.
Step 1. Scroll down for details & analytics related to the paper.
Discover a range of citation analytics, paper references, a list of cited papers, and more.